Martin Javier San - Net Worth and Insider Trading
Martin Javier San Net Worth
The estimated net worth of Martin Javier San is at least $3 Million dollars as of 2025-04-29. Martin Javier San is the Chief Medical Officer of Arrowhead Pharmaceuticals Inc and owns about 198,497 shares of Arrowhead Pharmaceuticals Inc (ARWR) stock worth over $3 Million. Martin Javier San is also the CHIEF MEDICAL OFFICER of Athira Pharma Inc and owns about 35,841 shares of Athira Pharma Inc (ATHA) stock worth over $10,537. Details can be seen in Martin Javier San's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Martin Javier San has not made any transactions after 2025-01-02 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

Transaction Summary of Martin Javier San
Martin Javier San Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Martin Javier San owns 1 companies in total, including Arrowhead Pharmaceuticals Inc (ARWR) .
Click here to see the complete history of Martin Javier San’s form 4 insider trades.
Insider Ownership Summary of Martin Javier San
Ticker | Company | Transaction Date | Type of Owner |
---|---|---|---|
ARWR | Arrowhead Pharmaceuticals Inc | 2024-01-05 | Chief Medical Officer |
Martin Javier San Latest Holdings Summary
Martin Javier San currently owns a total of 2 stocks. Among these stocks, Martin Javier San owns 198,497 shares of Arrowhead Pharmaceuticals Inc (ARWR) as of January 5, 2024, with a value of $3 Million and a weighting of 99.6%. Martin Javier San also owns 35,841 shares of Athira Pharma Inc (ATHA) as of January 2, 2025, with a value of $10,537 and a weighting of 0.4%.
Latest Holdings of Martin Javier San
Ticker | Company | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
ARWR | Arrowhead Pharmaceuticals Inc | 2024-01-05 | 198,497 | 13.30 | 2,640,010 |
ATHA | Athira Pharma Inc | 2025-01-02 | 35,841 | 0.29 | 10,537 |
Holding Weightings of Martin Javier San
Martin Javier San Form 4 Trading Tracker
According to the SEC Form 4 filings, Martin Javier San has made a total of 5 transactions in Arrowhead Pharmaceuticals Inc (ARWR) over the past 5 years, including 0 buys and 5 sells. The most-recent trade in Arrowhead Pharmaceuticals Inc is the sale of 8,303 shares on January 5, 2024, which brought Martin Javier San around $292,764.
According to the SEC Form 4 filings, Martin Javier San has made a total of 1 transactions in Athira Pharma Inc (ATHA) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in Athira Pharma Inc is the sale of 10,826 shares on January 2, 2025, which brought Martin Javier San around $6,063.
Insider Trading History of Martin Javier San
- 1
Martin Javier San Trading Performance
Martin Javier San Ownership Network
Ownership Network List of Martin Javier San
Ownership Network Relation of Martin Javier San

Martin Javier San Owned Company Details
What does Arrowhead Pharmaceuticals Inc do?
Who are the key executives at Arrowhead Pharmaceuticals Inc?
Martin Javier San is the Chief Medical Officer of Arrowhead Pharmaceuticals Inc. Other key executives at Arrowhead Pharmaceuticals Inc include director & President and CEO Christopher Richard Anzalone , CFO Kenneth Allen Myszkowski , and General Counsel Patrick O'brien .
Arrowhead Pharmaceuticals Inc (ARWR) Insider Trades Summary
Over the past 18 months, Martin Javier San made 2 insider transaction in Arrowhead Pharmaceuticals Inc (ARWR) with a net sale of 28,003. Other recent insider transactions involving Arrowhead Pharmaceuticals Inc (ARWR) include a net sale of 622,793 shares made by Christopher Richard Anzalone , a net sale of 85,112 shares made by James C Hamilton , and a net sale of 101,271 shares made by Kenneth Allen Myszkowski .
In summary, during the past 3 months, insiders sold 492,547 shares of Arrowhead Pharmaceuticals Inc (ARWR) in total and bought 0 shares, with a net sale of 492,547 shares. During the past 18 months, 959,377 shares of Arrowhead Pharmaceuticals Inc (ARWR) were sold and 3,000 shares were bought by its insiders, resulting in a net sale of 956,377 shares.
Arrowhead Pharmaceuticals Inc (ARWR)'s detailed insider trading history can be found in Insider Trading Tracker table.
Arrowhead Pharmaceuticals Inc Insider Transactions
Martin Javier San Mailing Address
Above is the net worth, insider trading, and ownership report for Martin Javier San. Based on the public information released on the U.S. Securities and Exchange Commission (SEC) website, Martin Javier San's mailing address is: Pasadena Ca 91105.